United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
498.65
-15.17 (-2.95%)
Mar 3, 2026, 4:00 PM EST - Market closed

United Therapeutics Revenue

In the year 2025, United Therapeutics had annual revenue of $3.18B with 10.61% growth. United Therapeutics had revenue of $790.20M in the quarter ending December 31, 2025, with 7.38% growth.

Revenue (ttm)
$3.18B
Revenue Growth
+10.61%
P/S Ratio
6.87
Revenue / Employee
$2,273,357
Employees
1,400
Market Cap
21.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.18B305.30M10.61%
Dec 31, 20242.88B549.90M23.63%
Dec 31, 20232.33B391.20M20.20%
Dec 31, 20221.94B250.80M14.88%
Dec 31, 20211.69B202.20M13.63%
Dec 31, 20201.48B34.50M2.38%
Dec 31, 20191.45B-179.00M-11.00%
Dec 31, 20181.63B-97.50M-5.65%
Dec 31, 20171.73B126.50M7.91%
Dec 31, 20161.60B133.00M9.07%
Dec 31, 20151.47B177.30M13.76%
Dec 31, 20141.29B171.52M15.36%
Dec 31, 20131.12B200.91M21.93%
Dec 31, 2012916.08M172.89M23.26%
Dec 31, 2011743.18M150.28M25.35%
Dec 31, 2010592.90M234.02M65.21%
Dec 31, 2009358.88M77.38M27.49%
Dec 31, 2008281.50M70.55M33.45%
Dec 31, 2007210.94M51.31M32.14%
Dec 31, 2006159.63M43.72M37.71%
Dec 31, 2005115.92M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition